Medicare Enrolled
Dr. Robert Rhodes, M.D.
Dermatology · Ridley Park, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rhodes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rhodes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rhodes
Dr. Robert Rhodes is a dermatology specialist in Ridley Park, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rhodes performed 3,437 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rhodes received a total of $24,894 from 36 pharmaceutical and/or device companies across 592 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rhodes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 28% volume in PA
$24,894 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,437
Medicare services
Top 28% in PA for dermatology
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,330 | $5 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
846 | $91 | $135 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
542 | $49 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
206 | $66 | $95 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 158 | $66 | $140 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
107 | $101 | $195 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
56 | $204 | $304 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
39 | $133 | $195 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
29 | $137 | $195 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
26 | $201 | $296 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
20 | $82 | $115 |
| Skin cancer removal, face or mouth area, 0.6-1.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 0.6 and 1.0 centimeters. |
20 | $174 | $270 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
17 | $169 | $263 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
16 | $128 | $170 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
14 | $210 | $290 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
11 | $229 | $320 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$24,894
Total received (2018-2024)
Avg $3,556/year across 7 years
Top 9% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
592
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,242
2023
$2,497
2022
$2,049
2021
$1,451
2020
$998
2019
$2,317
2018
$13,341
Payments by company (2024)
Dermavant Sciences, Inc.
$351
Janssen Biotech, Inc.
$297
UCB, Inc.
$290
ABBVIE INC.
$259
Lilly USA, LLC
$213
Regeneron Healthcare Solutions, Inc.
$201
Novartis Pharmaceuticals Corporation
$153
Arcutis Biotherapeutics, Inc.
$133
SUN PHARMACEUTICAL INDUSTRIES INC.
$119
LEO Pharma Inc.
$74
Amgen Inc.
$63
MAYNE PHARMA COMMERCIAL LLC
$59
E.R. Squibb & Sons, L.L.C.
$15
GENZYME CORPORATION
$15
Top 3 companies account for 41.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$4,909
Promius Pharma LLC
$4,418
UCB, Inc.
$3,954
Lilly USA, LLC
$1,786
ABBVIE INC.
$1,303
Dermavant Sciences, Inc.
$888
AbbVie, Inc.
$885
Ortho Dermatologics, a division of Bausch Health US, LLC
$879
Regeneron Healthcare Solutions, Inc.
$876
Novartis Pharmaceuticals Corporation
$766
AbbVie Inc.
$550
Sandoz Inc.
$418
Arcutis Biotherapeutics, Inc.
$367
LEO Pharma Inc.
$323
Amgen Inc.
$320
SUN PHARMACEUTICAL INDUSTRIES INC.
$281
Sun Pharmaceutical Industries Inc.
$279
GENZYME CORPORATION
$259
Journey Medical Corporation
$243
MAYNE PHARMA COMMERCIAL LLC
$160
Incyte Corporation
$158
MAYNE PHARMA INC.
$127
Mayne Pharma Inc.
$105
Celgene Corporation
$100
Galderma Laboratories, L.P.
$95
E.R. Squibb & Sons, L.L.C.
$79
SANOFI-AVENTIS U.S. LLC
$72
PruGen, Inc. Pharmaceuticals
$71
PFIZER INC.
$57
VYNE Pharmaceuticals Inc.
$42
Taro Pharmaceuticals USA, Inc.
$33
Almirall LLC
$23
Alnylam Pharmaceuticals Inc.
$21
EPI Health, LLC
$19
Novum Pharma, LLC
$18
TARO PHARMACEUTICALS USA, INC.
$11
Top 3 companies account for 53.4% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · APEXICON E · Accutane · Alcortin A · BRYHALI · Bimzelx · CLODERM · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Exelderm · GIVLAARI · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Halog · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · LIBTAYO · NATRELLE SALINE-FILLED BREAST IMPLANTS · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Otezla · PICATO · QBREXZA · RETIN-A · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · Sernivo Spray 120ml · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tremfya · USP) 0.1% · VTAMA · Veltin · Winlevi · XOLAIR · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
331
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
CROZER CHESTER MEDICAL CENTER
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rhodes is a clinical cardiology specialist, with above-average Medicare volume (top 28% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rhodes experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Rhodes performed 1,330 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rhodes receive payments from pharmaceutical companies?
Yes. Dr. Rhodes received a total of $24,894 from 36 companies across 592 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rhodes's costs compare to other dermatologists in Ridley Park?
Dr. Rhodes's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rhodes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Ridley Park
Browse dermatologists in Ridley Park ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in PA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in PA
Which PA dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Promius Pharma LLC Payments to Doctors
See all physicians who received payments from Promius Pharma LLC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology